ASTRAZENECA PLC reports

Company location: Cambridge
Fiscal year end: 31 December

ASTRAZENECA PLC has filed 2,049 SEC EDGAR filings since 13 Mar 1995

Filter by type:
SC13D
SC13G
20-F
6-K

SEC filing history

Showing 326-350 of 1,000 matching filings.

Per page

25

Current page

14

20-F File 001-11960

FORM 20-F

Filing date: 20 Feb 2024
Reporting date: 31 Dec 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

6-K File 001-11960

FORM 6-K

Filing date: 20 Feb 2024
Reporting date: 20 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-11960

ANNUAL FINANCIAL REPORT

Filing date: 20 Feb 2024
Reporting date: 20 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

SC TO-T/A

SC TO-T/A

Filing date: 20 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-11960

FORM 6-K

Filing date: 20 Feb 2024
Reporting date: 20 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-11960

ASTRAZENECA COMPLETES ACQUISITION OF ICOSAVAX

Filing date: 20 Feb 2024
Reporting date: 20 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-11960

TAGRISSO PLUS CHEMO APPROVED IN US FOR LUNG CANCER

Filing date: 20 Feb 2024
Reporting date: 20 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-11960

FDA ACCEPTS DATO-DXD BLA FOR NONSQUAMOUS NSCLC

Filing date: 20 Feb 2024
Reporting date: 20 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-11960

TAGRISSO IMPROVED PFS IN STAGE III LUNG CANCER

Filing date: 20 Feb 2024
Reporting date: 19 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

SC TO-T/A

SC TO-T/A

Filing date: 15 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SC 13G/A

Filing date: 12 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-11960

FINAL RESULTS

Filing date: 08 Feb 2024
Reporting date: 08 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-11960

TOTAL VOTING RIGHTS

Filing date: 01 Feb 2024
Reporting date: 01 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-55247

SC 13G/A filing

Filing date: 24 Jan 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC TO-T/A

SC TO-T/A

Filing date: 19 Jan 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-11960

FORM 6-K

Filing date: 19 Jan 2024
Reporting date: 19 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

SC TO-T/A

SC TO-T/A

Filing date: 11 Jan 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 10 Jan 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-11960

TOTAL VOTING RIGHTS

Filing date: 02 Jan 2024
Reporting date: 02 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

SC TO-T

SC TO-T

Filing date: 27 Dec 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-11960

ASTRAZENECA ACQUIRES GRACELL

Filing date: 27 Dec 2023
Reporting date: 27 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-11960

FORM 6-K

Filing date: 26 Dec 2023
Reporting date: 26 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-11960

WAINUA (EPLONTERSEN) GRANTED FIRST US FDA APPROVAL

Filing date: 22 Dec 2023
Reporting date: 22 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-11960

DIRECTOR/PDMR SHAREHOLDING

Filing date: 14 Dec 2023
Reporting date: 14 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC TO-C

SC TO-C

Filing date: 12 Dec 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .